» Articles » PMID: 34604097

Advanced Nano-Carriers for Anti-Tumor Drug Loading

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Oct 4
PMID 34604097
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Chemotherapy is one of the important means of tumor therapy. However, most of the anti-tumor drugs that currently used in clinic are hydrophobic non-specific drugs, which seriously affect the efficacy of drugs. With the development of nanotechnology, drug efficacy can be improved by selecting appropriate biodegradable nanocarriers for achieving the controlled release, targeting and higher bioavailability of drugs. This paper reviewed the research progress of anti-tumor drug nanoparticle carriers, which mainly summarized the materials used for anti-tumor drug nanoparticle carriers and their effects in anti-tumor drugs, as well as the targeted drug delivery methods of anti-tumor drugs based on nanocarriers.

Citing Articles

A novel process for transcellular hemoglobin transport from macrophages to cancer cells.

Braniewska A, Skorzynski M, Sas Z, Dlugolecka M, Marszalek I, Kurpiel D Cell Commun Signal. 2024; 22(1):570.

PMID: 39605056 PMC: 11603754. DOI: 10.1186/s12964-024-01929-8.


Current status and prospects of MIL-based MOF materials for biomedicine applications.

Lin Z, Liao D, Jiang C, Nezamzadeh-Ejhieh A, Zheng M, Yuan H RSC Med Chem. 2023; 14(10):1914-1933.

PMID: 37859709 PMC: 10583815. DOI: 10.1039/d3md00397c.


Recent Advances in Nanobiotechnology for the Treatment of Non-Hodgkin's Lymphoma.

Liu S, Xu M, Zhong L, Tong X, Qian S Mini Rev Med Chem. 2023; 24(9):895-907.

PMID: 37724679 DOI: 10.2174/1389557523666230915103121.


The Art of War with : Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy.

Avakh A, Grant G, Cheesman M, Kalkundri T, Hall S Antibiotics (Basel). 2023; 12(8).

PMID: 37627724 PMC: 10451789. DOI: 10.3390/antibiotics12081304.


Smart Polymeric Nanoparticles in Cancer Immunotherapy.

Yu Z, Shen X, Yu H, Tu H, Chittasupho C, Zhao Y Pharmaceutics. 2023; 15(3).

PMID: 36986636 PMC: 10056399. DOI: 10.3390/pharmaceutics15030775.


References
1.
Robbins P, Ghivizzani S . Viral vectors for gene therapy. Pharmacol Ther. 1998; 80(1):35-47. View

2.
Yang H, Hua M, Liu H, Huang C, Tsai R, Lu Y . Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas. Biomaterials. 2011; 32(27):6523-32. DOI: 10.1016/j.biomaterials.2011.05.047. View

3.
Yin H, Kanasty R, Eltoukhy A, Vegas A, Dorkin J, Anderson D . Non-viral vectors for gene-based therapy. Nat Rev Genet. 2014; 15(8):541-55. DOI: 10.1038/nrg3763. View

4.
Wu G, Li J, Yue J, Zhang S, Yunusi K . Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma. Mol Med Rep. 2017; 17(2):2456-2464. PMC: 5783491. DOI: 10.3892/mmr.2017.8185. View

5.
Shalaby S, Khater M, Perucho A, Mohamed S, Helwa I, Laknaur A . Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells. Fertil Steril. 2016; 105(6):1638-1648.e8. PMC: 4971775. DOI: 10.1016/j.fertnstert.2016.03.001. View